Glycated Albumin Assay Market Huge Growth in Future Scope 2021-2028 | Asahi Kasei Corporation, Diazyme Laboratories, Inc., LifeSpan BioSciences

Glycated Albumin Assay Market Continues To Grow Due To Increasing Prevalence of Diabetes

Global Glycated Albumin Assay Market, by Product Type (Human Glycated Albumin Assay and Animal Glycated Albumin Assay), by Application (Diagnostics (Prediabetes, Type 1 Diabetes, and Type 2 Diabetes) and Research), by End User (Hospital, Diagnostic Centers, Research Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis

The global glycated albumin assay market is estimated to be valued at US$ 776.5 Million million in 2027 and is expected to exhibit a CAGR of 7.7% over the forecast period, as highlighted in a new report published by Coherent Market Insights.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1915

Market Overview:

Glycated albumin is calculated as the percentage of glycated albumin in total albumin. Albumin is the most common type of protein found in the blood and is replaced in around every 20-25 days. Albumin provides the body with the protein needed to both maintain growth and repair tissues. Glycated albumin is a novel biomarker use to detect and manage diabetes. It has also gained importance in glycemic monitoring for diabetes mellitus.

Albumin is present in blood, as well as in organs and body fluids. Albumin plays an essential role in the regulation of hormones, supplements, and certain medications in the body. Glycated albumin is progressively linked to a wide variety of diabetes complications, such as neuropathy, cardiovascular ailment, ceaseless kidney illness, and different conditions detectable to confined slender stream. Glycated albumin more accurately reflects changes in plasma glucose during the short term and postprandial plasma glucose.

Competitive Landscape:

Major players operating in the global glycated albumin assay market are DxGen Corp., Epinex Diagnostics Inc., Ethos Biosciences, Inc., Abnova Corporation, AMS Biotechnology (Europe) Limited, DRG International, Inc., Geno Technology, Inc., Abbexa Ltd., Biomatik Corporation, LifeSpan BioSciences, Diazyme Laboratories, Inc., Asahi Kasei Corporation, and PathShodh Healthcare Private Limited.

Key Market Drivers:

Increasing prevalence of diabetes worldwide is expected to boost the growth of the glycated albumin assay market during the forecast period. Glycated albumin is considered as a potential tool for the diagnosis of diabetes. For instance, according to International Diabetes Federation (IDF), in 2019, 463 million adults (20-79 years) were living with diabetes and this number is expected to reach around 700 million by 2045.

Moreover, extensive research for the development of novel diagnostic approach and regulatory approval of such assays is expected to drive growth of the glycated albumin assay market. For instance, in July 2019, EKF Diagnostics announced the availability of FDA-approved liquid, enzymatic test for glycated albumin (GA), used for intermediate term monitoring of glycemic control in diabetes patients.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1915

COVID-19 Impact Analysis:

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization. COVID-19 is proving to be a more serious illness than seasonal flu in everyone, including people with diabetes. According to the World Health Organization (WHO), older people, and those with underlying medical problems like diabetes, cardiovascular disease, and cancer are more likely to develop serious illness. Type 2 diabetes is one of the main risk factors for developing severe COVID-19 due to too much inflammation, often called a cytokine storm. This in turn is expected to propel the growth of the glycated albumin assay market.

Key Takeaways:

• The glycated albumin assay market is expected to exhibit a CAGR of 7.7 % during the forecast period due to the increasing availability of novel glycated albumin assay around the world. For instance, in July 2018, Asahi Kasei Pharma and Stanbio Laboratory entered into an exclusive distribution agreement for the marketing of Lucica Glycated Albumin-L in the United States. Moreover, EKF is the exclusive distributor of the Lucica Glycated Albumin-L test manufactured by Asahi-Kasei Pharma Corporation of Japan.

• Among regions, North America and Asia Pacific are expected to witness significant growth in the glycated albumin assay market due to increasing prevalence of diabetes and growing geriatric population in these regions. For instance, according to the American Diabetes Association, in 2018, around 34.2 million people in the U.S., or 10.5% of the population, had diabetes. Nearly 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents.

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/1915

Table of Contents:

1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Overview
o Report Description
• Market Definition and Scope
o Executive Summary
• Market Snippet By Product Type
• Market Snippet By Application
• Market Snippet By Technology
• Market Snippet By End User
• Market Snippet By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

o Market Dynamics
• Drivers
• Restraints
• Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis

4. Global Glycated Albumin Assay Market, By Product Type, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Reagents & Consumables
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

5. Global Glycated Albumin Assay Market, By Application, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Genomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

6. Global Glycated Albumin Assay Market, By Technology, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Microarrays
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

7. Global Glycated Albumin Assay Market, By End User, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

8. Global Glycated Albumin Assay Market, By Regions, 2021 – 2028 (US$ Million)

o Introduction
• Market Share Analysis, By Region, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, For Regions, 2021 – 2028
o North America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• U.S.
• Canada
o Europe
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
o Asia Pacific
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
o Latin America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Brazil
• Mexico
• Rest of Latin America
o Africa
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• South Africa
• Central Africa
• North Africa
o Middle East
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• GCC
• Israel
• Rest of Middle East

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.